IP Verse

Bluebird Bio, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Bluebird Bio, Inc. opposed by its competitors

Patent:
EP3689899
Grant Date:
Nov 24, 2021
Title:
Mnd Promoter Chimeric Antigen Receptors
Oppositions:
1
Patent:
EP2760994
Grant Date:
Sep 15, 2021
Title:
Compounds For Improved Viral Transduction
Oppositions:
2
Patent:
EP3134095
Grant Date:
Apr 22, 2020
Title:
Improved Methods For Manufacturing Adoptive Cell Therapies
Oppositions:
3
Patent:
EP3134432
Grant Date:
Dec 25, 2019
Title:
Mnd Promoter Chimeric Antigen Receptors
Oppositions:
1
Patent:
EP3269802
Grant Date:
Oct 23, 2019
Title:
Compounds For Improved Viral Transduction
Oppositions:
2

Competitors of Bluebird Bio, Inc.

BOULT WADE TENNANT LLP

DEHNS LIMITED

GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED

Want to track Bluebird Bio, Inc.?

Feel free to send us a message here and we will get back to you